[Therapy of anxiety, mental anguish and sleeplessness. 3. Clinical pharmacological viewpoints].
D000437:Alcoholism / Q000188:drug therapy; D000438:Alcohols / Q000009:adverse effects; D000447:Aldehydes / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects*; D001381:Azepines / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D001965:Bromides / Q000009:adverse effects; D002707:Chlordiazepoxide / Q000009:adverse effects; D002719:Chlormethiazole / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008702:Methaqualone / Q000009:adverse effects; D009497:Neurotic Disorders / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects; D010880:Piperidines / Q000009:adverse effects; D011409:Propylene Glycols / Q000009:adverse effects; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014966:Xanthenes / Q000009:adverse effects
D000438:Alcohols; D000447:Aldehydes; D000928:Antidepressive Agents; D001381:Azepines; D001463:Barbiturates; D001965:Bromides; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D010880:Piperidines; D011409:Propylene Glycols; D014149:Tranquilizing Agents; D014966:Xanthenes; D002719:Chlormethiazole; D002707:Chlordiazepoxide; D008702:Methaqualone; D013881:Thioridazine
Behandling av oro, ångest och sömnsvårigheter. 3. Kliniskt farmakologiska synpunkter.